Literature DB >> 18810776

Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.

Jian-Qing Yang1, Guang-Dong Pan, Guang-Ping Chu, Zhen Liu, Qiang Liu, Yi Xiao, Lin Yuan.   

Abstract

AIM: To investigate the effects of interferon-alpha (IFN-alpha) to restrain the growth and invasive potential of hepatocellular carcinoma (HCC) induced by hepatitis B virus (HBV) X protein.
METHODS: The pcDNA3.1-HBx plasmid was transfected into Chang cells by Lipofectamine in vitro, and Chang/HBx was co-cultured with IFN-alpha. Cell survival growth curve and clonogenicity assay were used to test the growth potential of Chang/pcDNA3.1, Chang/HBx and IFN-alpha-Chang/HBx in vitro. Growth assay in nude mice was used to detect the growth potential of Chang/pcDNA3.1, Chang/HBx and IFN-alpha-Chang/HBx in vivo. Wound healing and transwell migration assays were used to detect the invasive ability of Chang/pcDNA3.1, Chang/HBx and IFN-alpha-Chang/HBx.
RESULTS: Compared with CCL13 cells transfected with pcDNA3.1, CCL13 with stable expression of hepatitis B virus X protein showed the characteristics of malignant cells with high capability of growth and invasion by detecting their growth curves, colony forming efficiency, wound healing , transwell migration assays and growth assays in nude mice. Its capability of growth and invasion could be controlled by IFN-alpha.
CONCLUSION: IFN-alpha can restrain the growth and invasive potential of HCC cells induced by HBx protein, which has provided an experimental basis for IFN-alpha therapy of HCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810776      PMCID: PMC2746345          DOI: 10.3748/wjg.14.5564

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Interferon decreases hepatocellular carcinogenesis in patients with cirrhosis caused by the hepatitis B virus: a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; M Kobayashi; A Tsubota; M Fukuda; I Koida; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  Cancer       Date:  1998-03-01       Impact factor: 6.860

2.  Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression.

Authors:  Margherita Melegari; Sarah K Wolf; Robert J Schneider
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues.

Authors:  Xiaodong Zhang; Nan Dong; Lihui Yin; Na Cai; Hongtao Ma; Jiacong You; Hang Zhang; Honghui Wang; Ran He; Lihong Ye
Journal:  J Med Virol       Date:  2005-11       Impact factor: 2.327

Review 4.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

Authors:  Motoi Kondo; Hiroaki Nagano; Hiroshi Wada; Bazarragchaa Damdinsuren; Hirofumi Yamamoto; Nobuaki Hiraoka; Hidetoshi Eguchi; Atsushi Miyamoto; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

6.  Woodchuck hepatitis virus X protein is required for viral infection in vivo.

Authors:  F Zoulim; J Saputelli; C Seeger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

Review 7.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

8.  Activating mechanism of transcriptor NF-kappaB regulated by hepatitis B virus X protein in hepatocellular carcinoma.

Authors:  Tao Wang; Yi Wang; Meng-Chao Wu; Xin-Yuan Guan; Zheng-Feng Yin
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

9.  Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells.

Authors:  Man-Young Cha; Chang-Myeong Kim; Young-Min Park; Wang-Shick Ryu
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

10.  HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit.

Authors:  M Fischer; L Runkel; H Schaller
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

View more
  2 in total

1.  Adjuvant interferon for early or late recurrence of hepatocellular carcinoma and mortality from hepatocellular carcinoma following curative treatment: A meta-analysis with comparison of different types of hepatitis.

Authors:  Wei Zhang; Tian-Qiang Song; Ti Zhang; Qiang Wu; DA-Lu Kong; Qiang Li; Hui-Chuan Sun
Journal:  Mol Clin Oncol       Date:  2014-08-12

Review 2.  Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.

Authors:  Saad Shaaban; Amr Negm; Elsayed E Ibrahim; Ahmed A Elrazak
Journal:  Oncol Rev       Date:  2014-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.